These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2042691)

  • 1. Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis.
    Kaplan J; Ish-Shalom S
    Am J Med; 1991 Jun; 90(6):750-2. PubMed ID: 2042691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
    Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
    J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
    Minelli R; Gardini E; Bianconi L; Salvi M; Roti E
    J Endocrinol Invest; 1992 Dec; 15(11):853-5. PubMed ID: 1291598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of amiodarone-associated thyrotoxicosis.
    Franklyn JA; Gammage MD
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):662-6. PubMed ID: 17710087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
    Zosin I; Balaş M
    Endokrynol Pol; 2012; 63(1):2-9. PubMed ID: 22378090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
    Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.
    Roti E; Minelli R; Gardini E; Bianconi L; Braverman LE
    Arch Intern Med; 1993 Apr; 153(7):886-92. PubMed ID: 8466380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease.
    Martino E; Aghini-Lombardi F; Bartalena L; Grasso L; Loviselli A; Velluzzi F; Pinchera A; Braverman LE
    Arch Intern Med; 1994 Dec 12-26; 154(23):2722-6. PubMed ID: 7993156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis.
    Cappiello E; Boldorini R; Tosoni A; Piraneo S; Bernasconi R; Raggi U
    J Endocrinol Invest; 1995 Dec; 18(11):862-8. PubMed ID: 8778159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone: a common source of iodine-induced thyrotoxicosis.
    Martino E; Aghini-Lombardi F; Mariotti S; Bartalena L; Braverman L; Pinchera A
    Horm Res; 1987; 26(1-4):158-71. PubMed ID: 2885251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amiodarone-induced thyroid gland dysfunctions].
    Gassanov N; Dietlein M; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Apr; 135(16):807-11. PubMed ID: 20391312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine excess and hyperthyroidism.
    Roti E; Uberti ED
    Thyroid; 2001 May; 11(5):493-500. PubMed ID: 11396708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyroid dysfunction in long-term amiodarone administration. Correlation of the antiarrhythmic activity of amiodarone with its effect on thyroid function].
    Serdiuk SE; Bakalov SA; Golitsyn SP; Sitina VK; Molashenko NV; Platonova NM; Sviridenko NIu
    Kardiologiia; 2005; 45(1):22-7. PubMed ID: 15699935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Hofmann A; Nawara C; Ofluoglu S; Holzmannhofer J; Strohmer B; Pirich C
    Wien Klin Wochenschr; 2008; 120(15-16):493-8. PubMed ID: 18820854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone-induced thyroid gland dysfunction.
    Mechlis S; Lubin E; Laor J; Margaliot M; Strasberg B
    Am J Cardiol; 1987 Apr; 59(8):833-5. PubMed ID: 3825945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced thyroid dysfunction.
    Ross IL; Marshall D; Okreglicki A; Isaacs S; Levitt NS
    S Afr Med J; 2005 Mar; 95(3):180-3. PubMed ID: 15832669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid dysfunction induced by amiodarone].
    Posadas C; Olguín R; Baltazares E; Molina L; González C
    Arch Inst Cardiol Mex; 1985; 55(5):399-404. PubMed ID: 2935096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMIODARONE AND THYROID DYSFUNCTION.
    Medić F; Bakula M; Alfirević M; Bakula M; Mucić K; Marić N
    Acta Clin Croat; 2022 Aug; 61(2):327-341. PubMed ID: 36818930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
    Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ
    Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.